405 filings
6-K
IPCIF
Intellipharmaceutics International Inc.
5 Dec 19
Primary Document
9:36am
6-K
IPCIF
Intellipharmaceutics International Inc.
25 Nov 19
Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. for Venlafaxine ER
4:39pm
SC 13D/A
IPCIF
Intellipharmaceutics International Inc.
18 Nov 19
Intellipharmaceutics International Inc.
5:03pm
6-K
IPCIF
Intellipharmaceutics International Inc.
18 Nov 19
Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing
4:38pm
6-K
IPCIF
Intellipharmaceutics International Inc.
7 Nov 19
Intellipharmaceutics Announces Settlement Agreement in Class Action Lawsuit, Which is Subject to Court Approval
4:20pm
6-K
komib
24 Oct 19
Intellipharmaceutics Update on its Oxycodone ER New Drug Application
1:48pm
6-K
9xn7i8euj3 u4ecc
11 Oct 19
Primary Document
5:20pm
6-K
dmk47hh8cz5fakcmpdw
4 Oct 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
8:07am
6-K
wtvekdpuntr29w
5 Sep 19
Primary Document
1:44pm
6-K
sog4yg9k91bpa
15 Aug 19
Primary Document
3:28pm
6-K
cbi12w0rpc 2x
24 Jul 19
Update on its Oxycodone ER New Drug Application
5:13pm
6-K
9hrjj
10 Jul 19
Primary Document
5:08pm
6-K
aro6af
8 Jul 19
Primary Document
5:18pm
25-NSE
6s5wrucrulqfmbmtc
3 Jun 19
Exchange delisting
9:59am
6-K
izawy6ve2egz
30 May 19
Intellipharmaceutics Announces Receipt of Cannabis Drug License from Health Canada
8:51am
6-K
h7oyxb3d7r
29 May 19
Intellipharmaceutics Reports Director Election Results
5:07pm
424B3
ys9gd7fy35uby98kt
29 May 19
Prospectus supplement
3:18pm
424B3
bjml c41kr
29 May 19
Prospectus supplement
3:13pm
6-K
vziqct noeajxrkfh8
29 May 19
Intellipharmaceutics to present at the 9th Annual LD Micro Invitational
9:38am
6-K
gi9fiiml
28 May 19
Annual & Special Meeting of Shareholders
4:41pm